• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FLOWONIX MEDICAL INC. PROMETRA PROGRAMMABLE PUMP; IMPLANTABLE INFUSION PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FLOWONIX MEDICAL INC. PROMETRA PROGRAMMABLE PUMP; IMPLANTABLE INFUSION PUMP Back to Search Results
Model Number 91827
Device Problem Insufficient Flow or Under Infusion (2182)
Patient Problems Itching Sensation (1943); Cramp(s) (2193); Discomfort (2330); Inadequate Pain Relief (2388); Underdose (2542); Cramp(s) /Muscle Spasm(s) (4521)
Event Date 02/03/2020
Event Type  Injury  
Manufacturer Narrative
Pending further follow-up information.(b)(4).
 
Event Description
Distributor reported, "irregular infusion with consequent crisis due to an iper or under drug dose and final infusion block and withdrawal symptoms." pump was explanted and replaced.
 
Event Description
Distributor reported, "irregular infusion with consequent crisis due to an iper or under drug dose and final infusion block and withdrawal symptoms." pump was explanted and replaced.During the follow up agent provided below additional following information: on (b)(6) 2020: patient visited first aid department for withdrawal symptoms and insufficient pain control, with itch and cramps.Patient began experiencing withdrawal symptom.(b)(6) 2020: patient experienced withdrawal symptoms.Following few days patient was sleepy.(b)(6) 2020: patient again experienced withdrawal symptoms and was sleepy for few days.(b)(6) 2020: patient's withdrawal symptom continued.During the pump refill, underinfusion was observed.Expected volume: 15 ml.Aspirated volume: 17ml.(b)(6) 2020: during the pump refill, underinfusion was noted.Expected volume: 16ml.Aspirated volume: 20ml.Morphine was administered to the patient subcutaneously through an elastomeric pump with resolution of withdrawal symptoms.(b)(6) 2020: patients pump was replaced.
 
Manufacturer Narrative
Product return was requested.Pending return of the explanted pump for further evaluation.Internal complaint # (b)(4).
 
Manufacturer Narrative
Additional information: g1 (second address).Corrected information: d9, g1, h3, h6.Device was returned for additional evaluation and investigation.A review of the device history record, which includes verification of all steps in the manufacturing of the pump, verification of all final testing performed by/on the pump, verification of sterilization, and packaging for subject pump was performed.The review did not identify any non-conformances, issues or capas associated with pump function.Additional physical investigation was performed on the device, confirming the alleged issue.Operation of the pump reservoir function was checked by filling the reservoir with 20ml of sterile water for injection and allowing the reservoir's pressure to return the fluid into the syringe.The reservoir was filled and the cap was flushed with 5ml of swi.A demand bolus of 0.300mg with a 1.00mg/ml concentration over 16 minutes was programmed with a programmer.Fluid droplets were observed at the tip of the stem indicating proper priming of the pump.The pump was programmed with a 1.994 mg daily dose multi-rate flow test over a 24- hour time period at 37 degrees for one day.The dispensed volume was 0% of the expected.The catheter access port and suture ring were removed and the pump was decontaminated a second time.The "pull open/hold open" currents were measured and the results showed that the current required to pull open both the inlet and outlet valves exceeded the design specification for the valve.The pump failed to flow to specification with both the inlet and outlet valves requiring a higher pull open current than the designed specification.Internal complaint number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMETRA PROGRAMMABLE PUMP
Type of Device
IMPLANTABLE INFUSION PUMP
Manufacturer (Section D)
FLOWONIX MEDICAL INC.
500 international drive
suite 200
mount olive, nj
MDR Report Key10115156
MDR Text Key193672611
Report Number3010079947-2020-00239
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00810335020310
UDI-Public(01)00810335020310(11)170425(17)190425
Combination Product (y/n)N
PMA/PMN Number
P080012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup,Followup
Report Date 05/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/25/2019
Device Model Number91827
Device Catalogue Number91827
Device Lot Number22954
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/27/2020
Date Manufacturer Received06/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-